Guardant Health (GH) PT Lowered to $130 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Guardant Health (GH) PT Lowered to $110 at Cowen
February 24, 2022 6:42 AM ESTCowen analyst Max Masucci lowered the price target on Guardant Health (NASDAQ: GH) to $110.00 (from $170.00) while maintaining an Outperform rating.
The analyst commented, "With the ECLIPSE trial readout expected in mid-2022, GH is approaching another landmark event for the field of cancer... More
Guardant Health (GH) PT Lowered to $115 at Wells Fargo
February 24, 2022 6:36 AM ESTWells Fargo lowered its price target on Guardant Health (NASDAQ: GH) to $115.00 (from $150.00) while maintaining a Overweight rating.... More
Guardant Health (GH) PT Lowered to $120 at Citi
February 24, 2022 5:41 AM ESTCiti analyst Patrick Donnelly lowered the price target on Guardant Health (NASDAQ: GH) to $120.00 (from $180.00) while maintaining a Buy rating.... More
Guardant Health (GH) Tops Q4 EPS by 46c
February 23, 2022 4:15 PM ESTGuardant Health (NASDAQ: GH) reported Q4 EPS of ($0.69), $0.46 better than the analyst estimate of ($1.15). Revenue for the quarter came in at $108 million versus the consensus estimate of $98.61 million.
GUIDANCE:
Guardant Health sees FY2022 revenue of $460-470 million, versus the consensus of... More
